HORIZON-JU-GH-EDCTP3-2024-01-two-stage
HORIZON-JU-GH-EDCTP3-2024-01-two-stage
- Programme
- HORIZON
- Funded projects (dataset)
- 32
- EU contribution (sum)
- €195,837,210
- Portal deadline
- —
Leading topic in historical projects: HORIZON-JU-GH-EDCTP3-2024-01-03-two-stage
Start here
Suggested partners for this call
Who coordinated consortia under this call, plus a complementary slice (topic leaders, research partners, or frequent non-coordinators). For industry lists, CSV export, and consortium size — open Proposal partner finder.
Top coordinators
Organisations that coordinated the most funded projects under this call.
- LSTM3 coordinated
- LSHTM3 coordinated
- IRD2 coordinated
- LMU MUENCHEN2 coordinated
- UOXF2 coordinated
- UNIVERSITY OF GLASGOW2 coordinated
- CIRAD1 coordinated
- UT1 coordinated
- FONDATION RAOUL FOLLEREAU1 coordinated
- ISGLOBAL1 coordinated
- GSK1 coordinated
- FOUNDATION FOR RESEARCH AND TECHNOLOGYHELLAS1 coordinated
Organisations strong on this topic
Broader signal: frequent participants across funded projects tagged with the same topic codes as this call (not limited to coordinators).
- KEMRI4 topic projects
- KNUST4 topic projects
- SWISS TPH SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE4 topic projects
- ARMAUER HANSEN RESEARCH INSTITUTE3 topic projects
- DNDI3 topic projects
- FM3 topic projects
- JU3 topic projects
- UU3 topic projects
- UBC2 topic projects
Frequent collaborators
Pairs that often appear together in the same funded project under this call.
- 4 shared
- 3 shared
- RADBOUDUMC · UEM2 shared
NL ↔ MZ
- 2 shared
- RADBOUDUMC · LOS ANGELES UCLA SANTA BARBARA UCSB DAVIS UCD RIVERSIDE UCR SAN DIEGO UCSD SANTA CRUZ UCSC IRVIN2 shared
NL ↔ US
- RADBOUDUMC · FONDAZIONE PENTA ETS2 shared
NL ↔ IT
- 2 shared
- 2 shared
- 2 shared
- 2 shared
- 2 shared
- 2 shared
- RADBOUDUMC · UNIVERSITY COLLEGE LONDON2 shared
NL ↔ UK
- RADBOUDUMC · WHC2 shared
NL ↔ ZA
- 2 shared
- AFRICAN PHARMACEUTICAL TECHNOLOGY FOUNDATION · SWISS TPH SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE2 shared
RW ↔ CH
- 2 shared
- 2 shared
Proposal partner finder
One page with suggested coordinators, strong and industry partners, topic leaders, typical consortium size, similar projects — plus CSV or print / PDF export for your shortlist.
Typical consortium pattern
Derived from historical funded projects linked to this CORDIS call in Grantibase.
- Avg. orgs / project
- 9.91
- Median orgs / project
- 10
- Min / max orgs
- 4 – 21
Country presence
Participant rows (an org can appear in multiple countries if data varies).
- United Kingdom30
- Kenya22
- Spain19
- France18
- Uganda17
- Germany15
- Ethiopia14
- Mozambique14
- South Africa14
- United States13
- Switzerland13
- Nigeria10
- Cameroon8
- Netherlands8
- Côte d’Ivoire7
- Italy7
- Ghana7
- Tanzania7
Organization types
- university85 orgs · 133 rows
- research_institute67 orgs · 114 rows
- public_body18 orgs · 21 rows
- other16 orgs · 20 rows
- company14 orgs · 18 rows
- sme11 orgs · 11 rows
Topics in funded projects
- HORIZON-JU-GH-EDCTP3-2024-01-03-two-stageHORIZON-JU-GH-EDCTP3-2024-01-03-two-stage· 8 projects
- HORIZON-JU-GH-EDCTP3-2024-01-06-two-stageHORIZON-JU-GH-EDCTP3-2024-01-06-two-stage· 7 projects
- HORIZON-JU-GH-EDCTP3-2024-01-04-two-stageHORIZON-JU-GH-EDCTP3-2024-01-04-two-stage· 5 projects
- HORIZON-JU-GH-EDCTP3-2024-01-05-two-stageHORIZON-JU-GH-EDCTP3-2024-01-05-two-stage· 5 projects
- HORIZON-JU-GH-EDCTP3-2024-01-01-two-stageHORIZON-JU-GH-EDCTP3-2024-01-01-two-stage· 4 projects
- HORIZON-JU-GH-EDCTP3-2024-01-02-two-stageHORIZON-JU-GH-EDCTP3-2024-01-02-two-stage· 3 projects
Related funded projects
Largest EU contributions in this call — useful to see who already won funding on similar lines.
Open full project list in advanced search
| Project | Programme | EU contribution |
|---|---|---|
| MVC-2G Optimising a Deployable High Efficacy Multi-Stage Vaccine for Plasmodium falciparum Malaria: 2nd Generation Malaria Vaccine Consortium | HORIZON | €14,999,800 |
| PfVIMT A Multi-stage Malaria Vaccine for Control and Elimination | HORIZON | €14,996,173 |
| EX-DR TB EX-DR TB: Elimination of Extensive Drug Resistance Through better Regimens for TB | HORIZON | €7,098,991 |
| CAD LUS4TB Computer assisted diagnosis with lung ultrasound for community based pulmonary tuberculosis triage in Benin, Mali and South-Africa | HORIZON | €6,809,786 |
| CHAPAS-5 CHAPAS-5: An Adaptive Platform Trial for Evaluation of Novel Treatment Regimens in ART-naive and Treatment-experienced Viraemic Children and Adolescents Living with HIV in Africa | HORIZON | €6,587,149 |
| ENABLE EARLY NEUTRALIZING ANTIBODIES IN INFANTS LIVING WITH HIV TO ENHANCE THEIR LIFE | HORIZON | €6,161,158 |
| VectorGrid-Africa Establishing a Network of Permanent Observatories for Mosquitoes and Mosquito-Borne Diseases in East and Southern Africa (VectorGrid-Africa) | HORIZON | €6,144,096 |
| ResTick Resilience Enhancement for Ticks and Tick-Borne Diseases in Sub-Saharan Africa | HORIZON | €6,130,555 |
| IMPACTING Integrated Multi-vector-borne diseases Platform to Assess how global Change impacts Transmission using Innovative systems modeling, Novel monitoring tools, and transmission blockinG micro-organisms | HORIZON | €6,113,863 |
| LASR Effect of long-acting spatial repellents (LASR) vs indoor residual spraying (IRS) on malaria burden in western Kenya: a cluster-randomised trial | HORIZON | €6,032,061 |
| TASP Tuberculosis Antimicrobial Stewardship Program (TASP): tackling Bedaquiline-resistant tuberculosis | HORIZON | €5,999,991 |
| PediSEP1 Risk stratified care to reduce antibiotic use and AMR transmission in African hospitals | HORIZON | €5,998,993 |
| DEFEND Delftia TsuruhatensTC1 Based-Intervention For Interrupting Malaria Transmission In Mosquitoes: A Novel Trial For Evaluating Alternative Tools For Control Of Vector-Borne Diseases | HORIZON | €5,952,882 |
| ComBac-Africa Combating Multidrug-Resistant Gram-Negative Bacteria in Africa through Diagnostic and Antimicrobial Stewardship | HORIZON | €5,869,999 |
| TEBULA Telacebec to Control Buruli Ulcer and Leprosy in Africa (TEBULA) | HORIZON | €5,768,415 |